Haemophilus Vaccines (Vaccine, Haemophilus)

Vaccines or candidate vaccines containing antigenic polysaccharides from Haemophilus influenzae and designed to prevent infection. The vaccine can contain the polysaccharides alone or more frequently polysaccharides conjugated to carrier molecules. It is also seen as a combined vaccine with diphtheria-tetanus-pertussis vaccine.
Also Known As:
Vaccine, Haemophilus; Haemophilus Vaccine; Hemophilus Vaccines; Vaccines, Haemophilus; Vaccines, Haemophilus influenzae; Vaccines, Hemophilus; Haemophilus influenzae Vaccines
Networked: 30 relevant articles (1 outcomes, 4 trials/studies)

Relationship Network

Bio-Agent Context: Research Results


1. Pommer, Peter: 1 article (01/2015)
2. Begue, Rodolfo: 1 article (06/2014)
3. Craver, Randall: 1 article (06/2014)
4. Springer, Jeffery: 1 article (06/2014)
5. Sevene, Esperança: 1 article (10/2013)
6. Bassat, Quique: 1 article (10/2013)
7. Sacoor, Charfudin: 1 article (10/2013)
8. Menendez, Clara: 1 article (10/2013)
9. Sigaúque, Betuel: 1 article (10/2013)
10. Sacarlal, Jahit: 1 article (10/2013)

Related Diseases

1. Infection
2. Tetanus
3. Whooping Cough (Pertussis)
4. Poliomyelitis (Polio)
11/01/1998 - "Safety and immunogenicity of a combined diphtheria-tetanus-acellular pertussis-inactivated polio vaccine-Haemophilus influenzae type b vaccine administered at 2-4-6-13 or 3-5-12 months of age."
12/15/2003 - "In this study, autoimmune diabetes-prone non-obese diabetic (NOD) mice were treated with two multivalent diphtheria, tetanus, pertussis, poliomyelitis and haemophilus vaccines (diphtheria, tetanus, acellular pertussis, inactivated polio (DTaP-IVP) or DTaP-IVP/Haemophilus influenza type b (Hib)) intraperitoneally at each of 10, 12 and 14 weeks of age. "
06/01/2010 - "The focus of the paper is immunogenicity studies for the following vaccines: tetanus, and diphtheria (toxoid vaccines), Haemophilus influenzae type b (Hib), meningococcal C (Men C) and pneumococcal (PnC) (subunit glycoconjugate vaccines), pertussis (subunit vaccine) and polio (inactivated vaccine). "
10/23/2007 - "In an open label, randomized, parallel group study, the liquid HV vaccine (HEXAVAC) (diphtheria, tetanus, 2-component acellular pertussis, inactivated poliomyelitis vaccine, Haemophilus influenzae type b conjugated to tetanus protein and hepatitis B) was administered at 2, 4, 6, and 12 months of age to all children. "
03/22/2007 - "Furthermore, co-administration of the combination vaccine with a combined diphtheria/tetanus/acellular pertussis/inactivated poliomyelitis vaccine/Haemophilus influenzae type b-TT conjugate (DTaP/IPV-Hib) vaccine to New Zealand white rabbits at a different injection site did not affect the anti-pneumococcal polysaccharide and anti-PorA antibody titres. "
5. Diphtheria

Related Drugs and Biologics

1. Vaccines
2. Pneumococcal Vaccines (Pneumococcal Polysaccharide Vaccine)
3. Diphtheria Toxoid (Vaccine, Diphtheria)
4. Hexavac
5. Haemophilus influenzae type b polysaccharide vaccine (HIB-vaccine)
6. Diphtheria-Tetanus-acellular Pertussis Vaccines (Tripedia)
7. Diphtheria-Tetanus Vaccine
8. Rubella Vaccine
9. Pertussis Vaccine
10. Membrane Proteins (Integral Membrane Proteins)